五养堂药业品牌怎么样 申请店铺

我要投票 五养堂药业在灵芝孢子粉行业中的票数:108 更新时间:2025-02-23
五养堂药业是哪个国家的品牌?「五养堂药业」是 浙江五养堂药业有限公司 旗下著名品牌。该品牌发源于浙江省丽水市,由创始人吴 * 谦在2004年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力五养堂药业品牌出海!通过在本页面挂载五养堂药业品牌的产品链接和联系邮箱,可以提高五养堂药业产品曝光!跨境电商爆单神器,目前只要100元/年哦~

五养堂药业怎么样

浙江五养堂药业有限公司使命是弘扬中医药五行养生文化,以现代生物科技制造灵芝、三叶青、铁皮石斛和红曲等道地药材的趁鲜口型中药饮片、保健食品、中药养生食品,以振兴中药保健食品产业和推动中药食疗食养、促进人类健康为己任,创新发展养肝(保肝明目)、养心(安心养神)、养脾(健脾益胃)、养肺(润肺养颜)、养肾(补肾益精)的五养系列健康产品,打造具有民族特色的中药保健养生和健康服务品牌。

浙江五养堂药业有限公司成立于2004年1月,其前身是浙江益圣菌物发展有限公司,由浙江省林业科学研究院、丽水市食用菌研究开发中心和吴学谦教授等40名自然人共同发起组建。2013年经严格的评估和公开挂牌交易,浙江省林业科学研究院的股份由吴学良等股东受让持有,国有股份全部退出,正式更名为“浙江五养堂药业有限公司”。

公司厂区占地面积20亩,建筑面积16000多平方米,建有中药饮片GMP车间、保健食品GMP车间、生物发酵车间、趁鲜冷冻超微破壁车间等四大健康产品生产线,目前是浙江省较大的灵芝破壁孢子粉、真菌多糖提取加工和三叶青口服型中药饮片趁鲜冷冻加工基地,产品远销欧美、日本、香港、台湾等国家和地区。

五养堂选育成功了“浙青1号“等新品种、掌握了三叶青的核心种植技术,已经申请了“一种果林地仿生套种袋式三叶青方法”等8项专利,通过三叶青趁鲜口服型加工技术改造和研发三叶青保健食品与抗菌抗炎退烧药品,拟从一产(规范种植)+二产(药品、保健食品加工)+三产(线上线下营销服务、健康服务、健康管理、健康保险、供应链管理)全产业链运作,将这一“天然的植物抗生素”三叶青产业做强做大。

五养堂将于2016年在新三板系统挂牌,并争取在1-2年内进入创新层,通过联合上市大企业搞定向增发,借助资本市场的力量将五养堂健康产业做强做大,实现百亿规模的企业梦想,并力求将五行中医药养生文化结合中国特色健康产品走向全世界。


The mission of Zhejiang wuyangtang Pharmaceutical Co., Ltd. is to carry forward the five elements health preservation culture of traditional Chinese medicine, to produce fresh Chinese herbal pieces, health food and health food of traditional Chinese medicine, such as Ganoderma lucidum, Trifolium, Dendrobium candidum and Monascus, with modern biotechnology, to revitalize the industry of health food of traditional Chinese medicine, promote the diet and nutrition of traditional Chinese medicine, and promote human health as its own duty, and innovate and develop the liver (liver protection Five series of health products, i.e. Mingmu, Yangxin (peace of mind and mind), yangpi (invigorating the spleen and stomach), Yangfei (moistening the lungs and beautifying the face) and Yangshen (invigorating the kidney and benefiting the essence), will build a brand of traditional Chinese medicine health care and health service with national characteristics. Zhejiang wuyangtang Pharmaceutical Co., Ltd. was founded in January 2004. Its predecessor is Zhejiang Yisheng fungus development Co., Ltd. which was jointly initiated and established by 40 natural persons including Zhejiang Academy of Forestry Sciences, Lishui edible fungus research and development center and Professor Wu Xueqian. In 2013, after strict evaluation and public listing, the shares of Zhejiang Academy of Forestry Sciences were transferred and held by Wu Xueliang and other shareholders, and all state-owned shares were withdrawn, officially renamed as "Zhejiang wuyangtang Pharmaceutical Co., Ltd.". The factory area of the company covers an area of 20 mu, with a building area of more than 16000 square meters. It has four major production lines for healthy products, including GMP workshop for Chinese herbal pieces, GMP workshop for health food, biological fermentation workshop, ultra-fine wall breaking workshop for fresh freezing. At present, it is a large base for the extraction and processing of Ganoderma lucidum wall breaking spore powder, fungal polysaccharide and Sanyeqing oral Chinese herbal pieces while fresh freezing in Zhejiang Province. The products are sold far Europe, America, Japan, Hong Kong, Taiwan and other countries and regions. Wuyangtang has successfully selected new varieties such as "zheqing No.1" and mastered the core planting technology of sanyeqin. It has applied for eight patents such as "a bionic interplanting bag type of sanyeqin in fruit forest". Through the technological transformation of sanyeqin taking advantage of the fresh oral processing technology and the research and development of sanyeqin health food and anti-bacterial, anti-inflammatory and fever reducing drugs, it is planned to produce from the first (standard planting) + the second (medicine, health food) Product processing) + three industries (online and offline marketing services, health services, health management, health insurance, supply chain management) operate in the whole industrial chain, making this "natural plant antibiotic" three leaf green industry stronger and bigger. Wuyangtang will be listed in the new three board system in 2016, and strive to enter the innovation layer within 1-2 years. Through joint listing of large enterprises to conduct targeted additional issuance, with the help of capital market, wuyangtang health industry will be stronger and bigger, and realize the enterprise dream of 10 billion scale, and strive to integrate the five elements of traditional Chinese medicine health culture with Chinese characteristics of health products to the world.

本文链接: https://brand.waitui.com/b6e82ab79.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

创维携手京东及京东方,发布京东首款定制百吋电视

36氪获悉,2月22日,创维联合京东、京东方(BOE),于京东方福州·灯塔工厂举办了新品战略发布会,发布了京东首款定制的100吋电视——创维JD100mini。该产品搭载了京东方定制研发的百吋类纸屏,运用防眩抗反光技术,为用户带来全新的视觉体验。

2小时前

全国首个垂直领域应急管理政务大模型在南京发布

36氪获悉,南京市应急管理局、南京市数据局2月21日与擎天科技联合发布全国首个垂直领域应急管理政务大模型——“宁安晴”。据南京市数据局有关人士介绍,“宁安晴”是基于南京政务云部署的DeepSeek—R1—671B满血版大模型深度定制开发,是“我的南京”政务版第一个专业部门智能体。采用南京政务云本地化部署,数据全链路加密并通过国家信息安全等级保护三级认证,确保敏感信息不出域。

2小时前

SpaceX计划于2月26日进行星舰第八次试飞

美国联邦航空管理局(FAA)发布通告称,埃隆・马斯克的火箭制造公司SpaceX计划最早于2月26日进行星舰(Starship)运载火箭的下一次测试飞行。该通告还指出,如果26日的发射计划无法实施,公司已选择了2月26日至3月6日之间的日期作为备用发射窗口。(IT之家)

2小时前

酷开AIOS已接入满血版DeepSeek-R1大模型

36氪获悉,2月21日,创维发布了2025年度旗舰产品——创维A5F Pro。发布会上,创维方面表示,酷开AIOS已正式接入满血版DeepSeek-R1大模型,在其加持下,酷开AI智能体不仅可以被动回应指令,还能主动洞悉用户需求,轻松完成跨应用操作、复杂任务拆解等智能任务。在智能交互场景中,酷开AI智能体支持多达23种方言识别与模糊语义理解,能在回答中直接提供影视、音乐等精准结果选项。

2小时前

奇瑞风云T8车型正式上市

36氪获悉,2月22日晚间,奇瑞风云T8正式上市,新车共推出6款版型,搭载奇瑞最新C-DM5.0混动系统,官方指导价10.39万元-15.09万元,限时价9.99万元起。

2小时前

本页详细列出关于鹤芝堂的品牌信息,含品牌所属公司介绍,鹤芝堂所处行业的品牌地位及优势。
咨询